AeroClean Announces Appointment of Timothy J. Scannell to Board of Directors
May 12 2022 - 1:00PM
AeroClean Technologies (“AeroClean” or the “Company”) (Nasdaq:
AERC), a pathogen elimination technology company harnessing
patented UV-C LED technology with Pūrgo™ to significantly reduce
and remove harmful pathogens to keep work, play and life going,
today announced the appointment of Timothy J. Scannell, former
President and Chief Operating Officer at Stryker, to its Board of
Directors (the “Board”). On May 11, 2022, the Board appointed Mr.
Scannell as a new director on the Board, chair of the Nominating
and Corporate Governance Committee and a member of the Compensation
Committee.
Mr. Scannell brings over 30 years of experience and success
delivering market-leading results from his leadership roles at
Stryker Corporation (NYSE: SYK) (“Stryker”), one of the world’s
leading medical technology companies. Mr. Scannell served as
President and Chief Operating Officer of Stryker between 2018 and
2021, overseeing all of Stryker’s commercial businesses and regions
globally. Prior to this, he served as group president for Stryker’s
MedSurg & Neurotechnology businesses for ten years. Mr.
Scannell currently serves as a director and non-executive chairman
of the Board of Directors for Insulet Corporation (Nasdaq: PODD)
and is a director on the boards of Novocure Limited (Nasdaq: NVCR),
Renalytix plc (Nasdaq: RNLX) and Collagen Matrix, Inc.
“Tim Scannell is a medical technology industry veteran with vast
experience and a tremendous track record of success. He drove
market leading sales and supported Stryker’s top tier M&A
results during his time at Stryker. He will be a great addition to
our Board,” said Jason DiBona, AeroClean’s Chief Executive Officer.
“Tim’s interest in joining our Board and helping advance our
mission is a testament to our Company’s vision. I welcome Tim to
the team and look forward to his contributions to the success of
AeroClean.”
“I am proud to join the Board of AeroClean. I look forward to
supporting and advancing AeroClean’s mission of keeping life going
with healthy, safe air solutions,” said Mr. Scannell. “I am
energized by AeroClean’s mission, impressed by their board and
management team, and enthusiastic about the Company’s opportunity
to build a great business with tremendous impact on millions of
lives in the years to come.”
About AeroClean Technologies
AeroClean is a pathogen elimination technology company on a
mission to keep work, play and life going—with continuous air
sanitization products called Pūrgo™ (pure-go). We create solutions
for hospitals, offices, and many shared spaces as well as elevators
and more. Pūrgo™ products feature SteriDuct™, a proprietary
technology developed by our best-in-class aerospace engineers,
medical scientists and innovators. Powered by SteriDuct™, our
solutions are medical grade, eradicating viral, fungal and
bacterial airborne pathogens. Our purpose is simple: to never stop
innovating solutions that keep people healthy and safe, so life
never stops. Learn more at aeroclean.com.
Media ContactDrew Tybusdrew@oakpr.com
Investor Relations ContactsRyan TylerChief
Financial Officer, AeroCleanRTyler@AeroClean.com
Brian PinkstonMATTIO Communicationsaeroclean@mattio.com
Renalytix (NASDAQ:RNLX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Renalytix (NASDAQ:RNLX)
Historical Stock Chart
From Sep 2023 to Sep 2024